Lipid Disorders
Dyslipidemia - Abnormal lipid levels, high LDL, low HDL
Hyperlipidemia -↑ lipid levels (total cholesterol, LDL, triglycerides)
Hypercholesterolemia - Total cholesterol > 200 mg/dL
Hypertriglyceridemia - Triglyceride > 150 mg/dL
Hyperlipoproteinemia - ↑ lipoproteins
Lipid Profile
- Total cholesterol: < 200
Borderline: 200-239
High: > 240
- Triglycerides: < 150
Borderline: 150-199
High: > 200
Very high: > 500
- LDL: < 100
Near optimal: 100-129
Borderline: > 130
High: > 160
Very high: > 190
- HDL: > 60
Low: < 40
LDL/HDL ratio:
♂< 3.5
♀ < 3.0
Atherosclerosis
HTN/inflammation ➔ endothelial dysfunction
Monocyte & lymphocyte invade compromised vessel
Platelets adhere to damaged ➔ inflammatory cytokines & platelet derived growth factor (PDGF)
PDGF ➔ migration and proliferation of smooth muscle cells ➔ fibroblasts differentiate into myofibroblasts
Macrophages, SMCs ingest cholesterol (oxidized LDL) ➔ lipid filled macrophages (foam cells) ➔ fatty streaks (atherosclerotic lesions)
Extracellular matrix with collagen ➔ fibrous plaque (atheroma)
Macrophages secrete matrix metalloproteinases ➔ break down fibrous cap
Intima calcified
Stress ➔ fibrous cap rupture ➔ exposure of thrombogenic material
Thrombus ➔ occlusion of vessel
Lipid Disorders
PATHO
Acquired: ↑ cholesterol ➔ ↑ cardiovascular risk from atherosclerosis
Lifestyle: DM, ↑BMI, ↓ SPA, ↑ etOH
β-blockers, thiazides, steroids, estrogen supplementation, antipsychotics
Hypothyroid, cholestasis, nephrotic syndrome, cushing disease
Genetic: ↑ risk of developing atherosclerosis at young age
Deficient or missing LDL receptors or ApoB GOF mutation (➔ ↑ LDL endocytosis)
Familial hypercholesterolemia
Heterozygote: Total cholesterol > 250; Homozygote (↑↑rare): Total cholesterol > 600
normal triglycerides
Familial combined hyperlipidemia (more common)
↑↑↑ total cholesterol, ↑ triglycerides
↑ VLDL production
Familial hypertriglyceridemia (MC)
Normal/↑ total cholesterol, ↑↑↑ triglycerides
SSX
Premature atherosclerosis likely has genetic source
CAD, aortic stenosis, PAD in young and seemingly healthy pt
Xanthoma: nodular lipid deposits in skin/tendon
Histology: Foam cells and multinucleated histiocytes (Touton giant cells)
Xanthelasma: yellow plaques on medial upper eyelid
Severe hypertriglyceridemia
Pancreatitis (pain radiating to back)
Lipemia retinalis (white vessels on fundo exam)
DX
Screening
Get lipid profile on new, young pts if they weren't screened as a child
Make sure familial lipid disorder isn't present
Get lipid profile if > 20yo without ASCVD but have family hx
Start lipid screening at 35yo in low risk
Starting Statin
Start statin if any manifestation of atherosclerotic cardiovascular disease
Stroke, MI/angina/HF, PAD, aortic atherosclerosis, thoracic or abdominal aortic aneurysm
Start statin if 40 - 75yo and diabetic (regardless of ASCVD risk)
Aim for LDL of 70
Start statin immediately if LDL ≥190
Initiate statin, aggressive lifestyle modifications, genetic screening
If LDL < 190:
20 - 39yo with↑ CVD risk (HTN, smoking, ↑ BMI / ↓ SPA, family hx of CHD)
Informal CVD risk estimate to determine statin initiation
40 - 75yo
Formal ASCVD risk assessment (10 year and lifetime risk) - 10 year risk > 7.5% ➔ start statin
Who wouldn't get a statin?
40-75yo with LDL < 70 and ASCVD risk < 7.5%
Can confirm that this ridiculously healthy pt with no RF doesn't need statin by coronary artery calcium (CAC) score of 0
CAC score 1-99 ➔ statin
Pregnant or breastfeeding
Liver disease
Taking amiodarone or protease inhibitors (HIV)
Addicted to grapefruit juice (like more than a cup a day) or crossfit
TX
Lifestyle changes (diet, fish oil, omega 3 FA, ↑ PA)
To ↓ LDL - Statin: Rosuvastatin (most potent)
Add ezetimibe if statin alone doesn't bring down LDL by 50%
Add bile acid sequestrants (cholestyramine) if statin + ezetimibe not effective
Add PCSK-9 in familial hypercholesterolemia not controlled on statin + ezetimibe
To ↑ HDL - Niacin
To ↓ triglycerides - Fibrates
AIM FOR:
Low LDL (< 100)
High HDL (> 40)
Triglycerides (< 150)
Total (< 200)
LDL:HDL (♂ < 3.5, ♀ < 3.0)